Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

510(k) form update

This article was originally published in The Gray Sheet

Executive Summary

Device center modifies 510(k) "indications for use" 1form to facilitate bundling of Rx/OTC premarket notifications. The old form asked sponsors to choose prescription use or over-the-counter use, while the updated form gives the option of OTC and/or Rx. With some devices, the main difference between prescription and OTC versions are different instructions for professional and lay audiences, CDRH explains, adding that sponsors may wish to bundle the premarket notifications. The device center also has modified its database to accommodate Rx/OTC 510(k)s. CDRH's in vitro diagnostics office in particular is "encouraging the immediate use" of the new form for "all 510(k) submissions"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel